Mechanisms, evidence,
and dosing precision.
Peer-reviewed research summaries on peptide biology — written for researchers, lab teams, and scientifically curious practitioners. All content is for informational and in vitro research reference only.
The most potent weight loss agent in clinical development. Phase 2 NEJM data, triple receptor mechanism, and how retatrutide surpasses semaglutide (Ozempic) and tirzepatide (Mounjaro).
How tirzepatide's dual incretin receptor mechanism produces superior weight loss to semaglutide — SURMOUNT trial analysis and the science behind Mounjaro and Zepbound.
The science behind Ozempic and Wegovy — GLP-1 receptor mechanism, STEP trial data (−14.9% body weight), and the landmark SELECT cardiovascular trial findings.
Why NAD+ drops 50% by age 60, how sirtuins govern epigenetic aging, and what the clinical data says about NMN and NR as NAD+ precursors for longevity research.
Molecular mechanisms, clinical evidence for skin and hair regeneration, and dosing precision for copper tripeptide in in vitro and ex vivo research models.
VEGF pathway activation, FAK-Paxillin signalling, musculoskeletal repair evidence, and gastrointestinal cytoprotection — a comprehensive mechanistic review of the body protection compound.
How GHK-Cu resets 4,000+ aging-associated genes, rebuilds the collagen extracellular matrix, and reactivates dormant hair follicles through Wnt/β-catenin, VEGF, and DHT pathway modulation.
